Kidney Res Clin Pract.  2021 Mar;40(1):99-108. 10.23876/j.krcp.20.022.

Clinical outcomes among hemodialysis patients with atrial fibrillation: a Korean nationwide population-based study

Affiliations
  • 1Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea
  • 2The Korean Society of Nephrology, Seoul, Republic of Korea
  • 3Department of Internal Medicine, Myongji Hospital, Hanyang University College of Medicine, Goyang, Republic of Korea
  • 4Health Insurance Review and Assessment Service, Wonju, Republic of Korea
  • 5Ewha Institute of Convergence Medicine, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea
  • 6Research Institute for Human Health Information, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea
  • 7Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Republic of Korea

Abstract

Background
The number of patients requiring dialysis is increasing worldwide, and the atrial fibrillation and atrial flutter (AF) prevalence among hemodialysis (HD) patients is higher than in the general population. There have been no studies of Korean AF patients undergoing HD that investigated how AF affects outcomes, such as all-cause mortality, hospitalization, and stroke events. We conducted a large-scale retrospective cohort study with data from the National Health Insurance System to determine how AF affects these outcomes.
Methods
In 2013, the Health Insurance Review and Assessment service, a Korean national health insurance scheme, collected data from 21,839 HD patients to evaluate the adequacy of dialysis centers. All-cause mortality, hospitalization, and stroke events were compared between patients with and without AF. Sub-analyses compared these outcomes between AF patients receiving warfarin and those not receiving warfarin.
Results
Cox regression analysis found that AF was a significant risk factor for death from any cause (hazard ratio [HR], 1.356; 95% confidence interval [CI], 1.222–1.506; p < 0.001), hospitalization (HR, 1.323; 95% CI, 1.225–1.430; p < 0.001), and hemorrhagic stroke (HR, 1.500; 95% CI, 1.050–2.141; p = 0.026). AF was not significantly associated with an increased risk of ischemic stroke. The use of warfarin was significantly associated with hemorrhagic stroke incidence (HR, 1.593; 95% CI, 1.075–2.360; p = 0.020), while there was no significant correlation between warfarin treatment and all-cause mortality, hospitalization, and ischemic stroke.
Conclusion
This cohort study of Korean dialysis patients showed that AF was a risk factor for multiple outcomes among HD patients.

Keyword

Atrial fibrillation; Hemodialysis; Hemorrhagic stroke; Hospitalization; Ischemic stroke; Mortality; Warfarin
Full Text Links
  • KRCP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr